<?xml version="1.0" encoding="UTF-8"?>
<ref id="B47">
 <label>47.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lambert</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Kinnear</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>McDonald</surname>
    <given-names>JU</given-names>
   </name>
   <name>
    <surname>Grodeland</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Bogen</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Stubsrud</surname>
    <given-names>E</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>DNA vaccines encoding antigen targeted to MHC class II induce influenza-specific CD8(+) T cell responses, enabling faster resolution of influenza disease</article-title>. 
  <source>Front Immunol.</source> (
  <year>2016</year>) 
  <volume>7</volume>:
  <fpage>321</fpage>. 
  <pub-id pub-id-type="doi">10.3389/fimmu.2016.00321</pub-id>
  <?supplied-pmid 27602032?>
  <pub-id pub-id-type="pmid">27602032</pub-id>
 </mixed-citation>
</ref>
